Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
First Claim
Patent Images
1. A method of inhibiting the release of a proinflammatory cytokine from a mammalian cell, the method comprising treating the cell with a cholinergic agonist in an amount sufficient to decrease the amount of the proinflammatory cytokine that is released from the cell, wherein the cell is a macrophage.
4 Assignments
0 Petitions
Accused Products
Abstract
A method of inhibiting the release of a proinflammatory cytokine in a cell is disclosed. The method comprises treating the cell with a cholinergic agonist. The method is useful in patients at risk for, or suffering from, a condition mediated by an inflammatory cytokine cascade, for example endotoxic shock. The cholinergic agonist treatment can be effected by stimulation of an efferent vagus nerve fiber, or the entire vagus nerve.
-
Citations
61 Claims
- 1. A method of inhibiting the release of a proinflammatory cytokine from a mammalian cell, the method comprising treating the cell with a cholinergic agonist in an amount sufficient to decrease the amount of the proinflammatory cytokine that is released from the cell, wherein the cell is a macrophage.
- 14. A method of inhibiting an inflammatory cytokine cascade in a patient, comprising treating the patient with a cholinergic agonist in an amount sufficient to inhibit the inflammatory cytokine cascade, wherein the patient is suffering from, or at risk for, a condition mediated by the inflammatory cytokine cascade.
- 24. A method for treating a patient suffering from, or at risk for, a condition mediated by an inflammatory cytokine cascade, the method comprising stimulating efferent vagus nerve activity of the patient sufficient to inhibit the inflammatory cytokine cascade.
-
32. A method for attenuation of a systemic inflammatory response to endotoxin in a patient, comprising stimulating efferent vagus nerve activity of the patient sufficient to inhibit an inflammatory cytokine cascade.
- 33. A method for determining whether a compound is a cholinergic agonist, the method comprising determining whether the compound inhibits the release of a proinflammatory cytokine from a mammalian cell.
Specification